Date:6/16/2008

for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve known and unknown risks and uncertainties, which could cause our actual results to differ materially from those described in the forward-looking statements. These risks include but are not limited to general economic and business conditions; our ability to implement our business and acquisition strategy; our ability to effectively integrate our acquisitions; competition; availability and retention of key personnel; our reliance on third party distributors, manufacturers and suppliers; changes in customer preferences; international sales and operations; the resolution of the SEC inquiry and litigation regarding our stock option practices; changes in, or the failure to comply with, government regulations; and other risks detailed from time-to-time in the Company's reports filed with the SEC, including the annual report on Form 10-K, for the fiscal year ended June 30, 2007. As a result of the foregoing and other factors, no assurance can be given as to future results, levels of activity and achievements and neither the Company nor any person assumes responsibility for the accuracy and completeness of these statements.

'/>"/>

SOURCE The Hain Celestial Group, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine news :

1. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
2. The Hain Celestial Group Announces the Acquisition of MaraNatha(R) and SunSpire(R) Brands
3. Vermillion, Inc. Announces Receipt of Notice of Noncompliance From Nasdaq
4. Pharsight Files Application for Nasdaq Capital Market Listing
5. Advanced Life Sciences Joins NASDAQ Capital Market
6. InfoLogix Announces Approval for NASDAQ Listing
7. TeamStaff Receives A Letter of Reprimand From Nasdaq; No Further Action Contemplated
8. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
9. Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2, 2007
10. Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market
11. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350